Additionally, the ApoE level showed a trend to increase, whereas ApoC-III was decreased in ICH-CAA patients compared with controls and AD patients, respectively, resulting in a higher ApoE/ApoC-III ratio in the ICH-CAA cohort compared to controls. Here, APOE is linked to Alzheimer disease.